Pricing Log in Create free account

Boundless Bio, Inc. (BOLD) vs Clene Inc. (CLNN)

Boundless Bio, Inc. and Clene Inc. are both Biotechnology companies. Boundless Bio, Inc. and Clene Inc. are of similar size ($56.4M and $54.8M). Boundless Bio, Inc. has the higher net margin (0.00% vs −11,271.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Clene Inc. leads on 6 and Boundless Bio, Inc. on 5.

Valuation

Metric BOLD CLNN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 211.59 9.40
P/B 0.83 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 196.34 9.02
Earnings yield (116.73%) (61.06%) (32.88%)
Free cash flow yield (103.14%) (33.01%) (23.13%)

Profitability

Metric BOLD CLNN Biotechnology median
Gross margin — 68.49% 68.51%
Operating margin 0.00% (8,928.57%) 0.00%
Net margin 0.00% (11,271.43%) 0.00%
Free cash flow margin 0.00% (6,984.45%) 0.00%
Return on equity (67.86%) 197.50% (51.96%)
Return on assets (50.56%) (120.65%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BOLD CLNN Biotechnology median
Revenue growth (TTM) — 11.21% 6.76%
EPS growth (last fiscal year) 32.47% 53.26% 29.88%
Revenue growth, 5-year CAGR — (0.59%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BOLD CLNN Biotechnology median
Debt to equity 0.00 (0.42) 0.00
Current ratio 9.48 0.85 4.97
Net debt to EBITDA 0.99 (0.39) 1.01

Dividend

Metric BOLD CLNN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BOLD CLNN Biotechnology median
Market cap 54.83m 56.43m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack